Quick Answer
AYTU BIOPHARMA, INC reported Research And Development Expense of $1.33 million for the year ending 2025.
- AYTU BIOPHARMA, INC showed a decrease of -52.1% in Research And Development Expense from 2024 to 2025.
- This data is from AYTU BIOPHARMA, INC's annual report (Form 10-K), filed with the SEC on September 23, 2025.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 12 years of available data (2014 to 2025), AYTU BIOPHARMA, INC's Research And Development Expense has declined by 66.3%.
- Historical annual values: Fiscal year 2025: $1.33 million | Fiscal year 2024: $2.77 million | Fiscal year 2023: $4.10 million | Fiscal year 2022: $12.66 million | Fiscal year 2021: $5.62 million | Fiscal year 2020: $1.72 million | Fiscal year 2019: $589.1 thousand | Fiscal year 2018: $167.6 thousand | Fiscal year 2017: $959.9 thousand | Fiscal year 2016: $6.13 million | Fiscal year 2015: $3.22 million | Fiscal year 2014: $3.93 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: